-
Project Title: Clinical Development of PDM608, a Potential Neuroprotective and Anti-inflammatory Long-acting Biologic for Parkinson’s Disease
… of 5 cohorts of 8 subjects each, while Part 2 is a multiple ascending dose study with 3 cohorts of 12 subjects …
-
Reporting on Stem Cells for Parkinson’s
August 16, 2023
… are starting to deliver on their therapeutic promise, with multiple stem cell therapies in clinical trials for …
-
Talking About Disease-modifying Therapies for Parkinson’s (Webinar Audio)
September 24, 2025
… neurologist, scientist and medical director of the Barlo Multiple Sclerosis Program at St. Michael’s hospital. She is …
-
NBD Peptides in MPTP Pre-clinical Model
… markedly inhibit the neuroinflammatory disease process of multiple sclerosis (MS) in animals and attenuate the …
-
CSM-101 TRPML1 Agonist for Parkinson’s Disease
… is a molecularly-targeted drug with potential to treat multiple forms of PD. Given that the current treatment …
-
Role of the JAK/STAT Pathway in Parkinson's Disease
… Our hypothesis is that monocytes and T-cells (immune system cells) from PD patients will exhibit heightened … PD, potentially in both the periphery and central nervous system, which may slow the neurodegenerative process. These …
Animations
Your search for “Multiple System Atrophy” returned 2623 results.